It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough

Business / Corporate Dec 28, 2022

Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough

by Kanoko Matsuyama

Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer’s biomarkers in blood tests.

Japan medical bodies aim to develop tailored drugs to treat rare diseases

National / Science & Health Dec 25, 2022

Japan medical bodies aim to develop tailored drugs to treat rare diseases

Japanese researchers plan to develop tailored drugs and treatments for patients with extremely rare diseases.

Japan approves blood test to detect Alzheimer’s

National / Science & Health Dec 22, 2022

Japan approves blood test to detect Alzheimer’s

Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon. Sysmex’s diagnostic product that measures amyloid beta in the ...

Injectable HIV treatment offers hope to Ugandan patients

World / Science & Health Dec 22, 2022

Injectable HIV treatment offers hope to Ugandan patients

Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.

Another Crispr first: New treatment wipes out teen's cancer

Commentary / World Dec 21, 2022

Another Crispr first: New treatment wipes out teen's cancer

by Lisa Jarvis

Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.

China’s reopening poses new challenges for itself and the world

Editorials Dec 16, 2022

China’s reopening poses new challenges for itself and the world

The situation in China is likely to get worse with the ending of the "zero-COVID" policy before it gets better, slowing its economy even more.

Despite unclear effectiveness, <i>kanpō</i> in short supply amid COVID wave

National / Science & Health Dec 15, 2022

Despite unclear effectiveness, kanpō in short supply amid COVID wave

by Tomoko Otake

The widespread use and availability of kanpō in Japan has given some people hope that it may work as a viable treatment for the viral disease.

Takeda to pay up to $6 billion for Nimbus immune-therapy drug

Business / Corporate Dec 14, 2022

Takeda to pay up to $6 billion for Nimbus immune-therapy drug

by John Lauerman

After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.

Shionogi says Japan government to buy 1 million more COVID pill doses

National / Science & Health Dec 13, 2022

Shionogi says Japan government to buy 1 million more COVID pill doses

The added supply agreement comes at a time when Japan is dealing with an eighth wave of COVID-19 infections.

Ex-Theranos president Ramesh Balwani gets 13-year prison term in fraud case

Business Dec 8, 2022

Ex-Theranos president Ramesh Balwani gets 13-year prison term in fraud case

by Joel Rosenblatt

Balwani and the company's founder, Elizabeth Holmes, had promised to revolutionize the medical industry by using a few drops of blood to complete a wide array of health tests.

Long ICU stays lead to extended misery for many COVID survivors

World / Science & Health Dec 6, 2022

Long ICU stays lead to extended misery for many COVID survivors

by Jason Gale

The mechanical ventilation, anti-inflammatory drugs and other tools of modern medicine that help people beat severe cases of COVID-19 often come with harrowing aftereffects.

Amgen has a contender in the weight-loss drug wars

Commentary / World Dec 2, 2022

Amgen has a contender in the weight-loss drug wars

by Lisa Jarvis

Amgen’s obesity drug offers a new twist on proven methods to help people lose unwanted pounds.

« 1 … 8 9 10 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times